Trade Unlisted is not regulated by the Securities and Exchange Board of India (SEBI). Investments in unlisted securities involve significant risk, including the risk of complete loss of capital. The filing of a Draft Red Herring Prospectus (DRHP) does not guarantee that an Initial Public Offering (IPO) will occur. Unlisted securities are inherently illiquid, price discovery may be limited, and exit opportunities may not materialize.
Trade Unlisted provides news, insights, and general market information for informational and educational purposes only. The content should not be construed as financial, investment, legal, or tax advice. Trade Unlisted does not act as a broker, investment advisor, fiduciary, or intermediary, and does not endorse, recommend, solicit, or validate any investment opportunity. Users are solely responsible for conducting their own independent due diligence before making any financial or investment decisions.
All information is derived from publicly available sources and market observations. While reasonable care is taken in preparing content, Trade Unlisted makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of the information provided. Users should independently verify all information prior to relying on it.
PharmEasy Partners with Samsung Health to Expand Affordable Digital Healthcare Access in India
Mumbai, India – February 2026: PharmEasy has partnered with Samsung Health to expand access to affordable and seamless healthcare services across India. The collaboration integrates PharmEasy’s medicine delivery, diagnostic testing, and teleconsultation services directly within the Samsung Health ecosystem.
The move strengthens India’s rapidly evolving digital healthcare landscape by bringing transactional healthcare services into a widely used wellness app.
What the Partnership Offers
Through a new feature called “Find Care”, Samsung Health users can:
- Order prescription and OTC medicines
- Book diagnostic lab tests
- Schedule online doctor consultations
All services are accessible without leaving the Samsung Health app, creating a more unified healthcare experience.
Integrated Healthcare Experience
Samsung Health traditionally focuses on fitness tracking — including heart rate monitoring, sleep tracking, activity tracking, and wellness insights. With PharmEasy’s integration, users can now move from health monitoring to healthcare action in a single platform.
This reduces friction in healthcare access and supports both preventive and reactive health management.
User Benefits
To drive adoption, eligible users will receive six months of complimentary PharmEasy Plus membership upon their first transaction. Benefits include:
- Discounted medicine pricing
- Free delivery options
- Exclusive health service offers
The initiative aims to make digital healthcare more accessible and cost-effective for users nationwide.
Why This Partnership Matters
India’s digital health ecosystem is witnessing rapid growth, with increasing demand for:
- Affordable medicine delivery
- Telemedicine services
- At-home diagnostic testing
- Integrated health-tech platforms
This collaboration signals a broader shift toward converged health ecosystems, where wellness tracking apps evolve into full-service healthcare platforms.
For PharmEasy, the partnership expands distribution reach through Samsung’s large device ecosystem. For Samsung Health, it enhances user stickiness by offering actionable healthcare services.
Source: https://www.biospectrumindia.com/news/16/27370/pharmeasy-joins-hands-with-samsung-health-to-expand-access-to-affordable-healthcare.html
Comments